- ￥4697
- OriGene
- AM20236PU-N
- 美国
- 2026年04月01日
- ELISA, FC, IHC
- Mouse
- Human
企业认证
相关产品推荐更多 >
Carrier-free (BSA/glycerol-free) PIM2 mouse monoclonal antibody, clone OTI8G10 (formerly 8G10)
￥3999Anti-IL18RAP Rabbit Polyclonal Antibody
￥1999
Carrier-free (BSA/glycerol-free) TCP11L2 mouse monoclonal antibody, clone OTI2H4 (formerly 2H4)
￥3999Rabbit Polyclonal Anti-CCDC124 Antibody
￥5250Carrier-free (BSA/glycerol-free) NAPSA mouse monoclonal antibody, clone OTI3A4
￥3999
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发，品质稳、品类全，实验不再等！Takara 秋促来袭，提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ￥1200阿拉丁 22万+ 科研级产品现货速发，品质严控、科研无忧- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
EGFR (Ligand binding Site) mouse monoclonal antibody, clone EGF-R1, Purified
- 抗体英文名：
EGFR (Ligand binding Site) mouse monoclonal antibody, clone EGF-R1, Purified
- 靶点：
EGFR
- 应用范围：
ELISA, FC, IHC
- 宿主：
Mouse
- 适应物种：
Human
- 保质期：
Stable for 12 months from date of receipt.
- 目录编号：
AM20236PU-N
- 级别：
科研级
- 库存：
5周
- 供应商：
OriGene
- 克隆性：
Monoclonal
- 保存条件：
Store lyophilized at 2-8°C for 6 months or at -20°C long term.After reconstitution store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C long term.Avoid repeated freezing and thawing.
- 形态：
PBS pH 7.4State: PurifiedState: Lyophilized purifed IgG fraction from Cell Culture SupernatantPreservative: 0.09% Sodium Azide
- 免疫原：
Human EGF-Receptor
- 规格：
100 ug
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Monoclonal Antibody Production
and screening of the hybridomas: 1. Bleeding Mice (1) Place the mouse in a mouse restrainer. (2) Sterilize the tail with 70% ethanol. (3) With a razor blade,nip off the last 2 mm of the tip of the tail. (4) Using a milking motion,pull blood down and let
Monoclonal Antibody Affinity Chromatography
all the above criteria and also afford the advantage of being available in essentially unlimited supply. Moreover, they are themselves readily purified, often by affinity chromatography. The main disadvantage of monoclonal antibody ligands is that they must possess
【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
技术资料暂无技术资料 索取技术资料
